-
Adults who haven't gotten any COVID-19 shots should consider the new option, the agency said Tuesday. The spike protein vaccine is more typical than the mRNA types being broadly used against COVID.
-
The BA.5 strain represented 65% of cases from July 3 to 9, according to data from the Centers of Disease Control and Prevention.
-
COVID-19 vaccines will soon be available to younger children in Vermont for the first time. On Saturday, the Centers for Disease Control and Prevention approved Pfizer and Moderna vaccines for children ages 6 months to 5 years old.
-
This hour, host Connor Cyrus talks with state Health Commissioner Dr. Mark Levine about the COVID-19 vaccine for the youngest Vermonters and other virus news.
-
CDC advisers are recommending the use of two separate COVID-19 vaccines for the youngest children made by Moderna and Pfizer-BioNTech, paving the way for vaccine rollout as early as next week.
-
Canada has had about 2.4 million cases of COVID-19 since December 2020. About 85% of the population has gotten at least one dose of a coronavirus vaccine, while about 82% has gotten two doses.
-
Pfizer plans to submit new data to the Food and Drug Administration this week, bringing families with young children one step closer to a long-awaited vaccine.
-
The chances of dying after receiving the Janssen vaccine is about 1:2,000,000. But with multiple COVID-19 vaccines available, the FDA is limiting the use of the J&J vaccine.
-
This hour we talk with Anne Sosin, a public health researcher at Dartmouth College, about centering health equity at this stage in the pandemic and in the months ahead.
-
After months of decline, Vermont is seeing an uptick in COVID-19 cases and hospitalizations. This hour, host Mikaela Lefrak speaks to Health Commissioner Dr. Mark Levine about the state's pandemic response.